Bionaut Labs
United States
- Los Angeles, CA
- 05/12/2022
- Series B
- $43,200,000
Bionauts™ are remote-controlled micro-robots revolutionizing the treatment of central nervous system disorders, targeting deep brain structures safely and precisely
- Industry Biotechnology Research
- Website https://bionautlabs.com/
- LinkedIn https://www.linkedin.com/company/bionaut-labs/
Related People
Michael ShpigelmacherCo Founder
United States -
Los Angeles, California,
I am a Biotech entrepreneur working on a stealth mode startup. Previously, I have spent over 6 years at PDT Partners (formerly Morgan Stanley), as a senior investment researcher creating proprietary investment strategies utilizing AI. Prior to PDT Partners I worked as an engagement manager at McKinsey and Company, where I led a team of consultants focusing on corporate strategy, operations, investment strategy and risk management. I primarily served clients in the healthcare and financial sectors.
Prior to McKinsey I have played a central role in the creation of a Primesense, the company developing the technology behind XBox Kinect and later acquired by Apple. Prior to Primesense, I spent 6 years as a senior product manager for a sophisticated governmental R&D organization. During this period I managed a team of up to 20 experienced engineers and researchers, dealing with complex software and hardware products, a challenging R&D process and close to impossible client requirements.
Specialties: Biotech, robotics, AI, R&D management, capital markets, investment management, risk management, hedging, portfolio optimization, operations, corporate strategy, organizational transformation, project management, product management, strategic planning, mathematical algorithm design, system engineering, financial engineering, software engineering
Tribe Stays | $2,800,000 | (Nov 18, 2025)
No Barrier Medical Translation | $2,700,000 | (Nov 18, 2025)
PowerLattice | $25,000,000 | (Nov 18, 2025)
Shipday | $7,000,000 | (Nov 18, 2025)
Muse Software | $4,500,000 | (Nov 18, 2025)
Artios | $115,000,000 | (Nov 18, 2025)
Scripta Therapeutics | $12,000,000 | (Nov 18, 2025)
Self Labs | $9,000,000 | (Nov 18, 2025)
Obello | $8,500,000 | (Nov 18, 2025)
AlertD | $3,000,000 | (Nov 18, 2025)
Skeletalis, Inc. | $8,000,000 | (Nov 18, 2025)
Span(US) | $25,000,000 | (Nov 18, 2025)